Lymphatic vessel involvement is predictive for lymph node metastasis and an important prognostic factor in endometrial cancer
…, H Aoyama, T Ooyama, Y Taira, Y Arakaki… - International journal of …, 2018 - Springer
Background Lymphovascular space involvement is reported to be an important risk factor in
endometrial cancer. This study was conducted to evaluate the separate prognostic effects of …
endometrial cancer. This study was conducted to evaluate the separate prognostic effects of …
Sarcopenia is an independent prognostic factor for squamous cell carcinoma of the cervix treated with concurrent chemoradiotherapy
S Kise, Y Arakaki, W Kudaka, T Ariga, N Kinjo… - Anticancer …, 2022 - ar.iiarjournals.org
Background/Aim: To investigate sarcopenia as a predictor of prognosis before concurrent
chemoradiotherapy (CCRT) in patients with squamous cell carcinoma (SCC) of the cervix …
chemoradiotherapy (CCRT) in patients with squamous cell carcinoma (SCC) of the cervix …
A phase II study of neoadjuvant chemotherapy followed by extended field concurrent chemoradiotherapy for para-aortic lymph node positive cervical cancer
…, J Heianna, T Nakasone, Y Taira, Y Arakaki… - Anticancer …, 2020 - ar.iiarjournals.org
Background/Aim: We conducted a phase II study of neoadjuvant chemotherapy followed by
extended field concurrent chemoradiotherapy in patients with cervical cancer with para-…
extended field concurrent chemoradiotherapy in patients with cervical cancer with para-…
Concurrent weekly cisplatin versus triweekly cisplatin with radiotherapy for locally advanced squamous-cell carcinoma of the cervix: a retrospective analysis from a …
…, T Nakasone, Y Taira, Y Arakaki… - The British Journal of …, 2017 - academic.oup.com
Objective: To compare patients with cervical cancer who were primarily treated with concurrent
chemoradiotherapy (CCRT) using 20 mg m −2 CDDP for 5 days every 3 weeks with …
chemoradiotherapy (CCRT) using 20 mg m −2 CDDP for 5 days every 3 weeks with …
Therapy-free interval has prognostic value in patients with recurrent cervical cancer treated with chemotherapy following definitive concurrent chemoradiotherapy
…, W Kudaka, Y Kinjyo, Y Taira, Y Arakaki… - Archives of Gynecology …, 2017 - Springer
Purpose Patients with cervical cancer recurrence after concurrent chemoradiotherapy (CCRT)
who are not candidates for surgical resection or salvage radiotherapy have a dismal …
who are not candidates for surgical resection or salvage radiotherapy have a dismal …
Long-term outcomes of cervical adenocarcinoma treated with concurrent chemoradiotherapy using paclitaxel and cisplatin
Y Arakaki, T Ariga, J Heianna, Y Shimoji, T Nakasone… - in vivo, 2020 - iv.iiarjournals.org
Background/Aim: We retrospectively analyzed the locally advanced adenocarcinoma (AC)/adenosquamous
carcinoma (ASC) of the uterine cervix treated with concurrent …
carcinoma (ASC) of the uterine cervix treated with concurrent …
Hysterectomy for recurrent/residual cervical cancer following definitive radiotherapy
T Nakasone, Y Taira, Y Shimoji, Y Arakaki, T Nakamoto… - in vivo, 2020 - iv.iiarjournals.org
Background/Aim: Radical hysterectomy has been used for local recurrent or persistent (LR)
cervical cancer after radiotherapy (RT), but the rate of serious complications is high and …
cervical cancer after radiotherapy (RT), but the rate of serious complications is high and …
[HTML][HTML] Microsurgical lymphaticovenular anastomosis for refractory chylous ascites following para-aortic lymph nodes dissection in a patient with tubal cancer
Y Arakaki, Y Shimoji, S Yamazaki… - Gynecologic oncology …, 2018 - ncbi.nlm.nih.gov
3. Discussion We report a case with chylous ascites refractory to conservative management,
which was successfully treated with LVA under local anesthesia.
which was successfully treated with LVA under local anesthesia.
[HTML][HTML] Comprehensive Genomic Profiling for Therapeutic Decision and Identification of Gene Mutation in Uterine Endometrial Dedifferentiated Carcinoma
Y Taira, Y Shimoji, Y Arakaki, T Nakamoto… - Case Reports in …, 2022 - karger.com
Endometrial dedifferentiated carcinoma is a new concept among endometrial malignancies,
is rare, and has a poor prognosis as it is discovered in advanced stages and has no …
is rare, and has a poor prognosis as it is discovered in advanced stages and has no …
Relative dose intensity and overall treatment time in older patients with cervical cancer treated with concurrent chemoradiotherapy
…, Y Shimoji, T Nakasone, Y Taira, Y Arakaki… - Journal of Geriatric …, 2021 - Elsevier
2. Methods We retrospectively analyzed patients with FIGO (International Federation of
Gynecology and Obstetrics) stage IB1 to IVA cervical cancer treated with the first CCRT during …
Gynecology and Obstetrics) stage IB1 to IVA cervical cancer treated with the first CCRT during …